×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Don’t Do It Alone: To De-Risk Your Next Trial, Seek Outside Expertise

March 28, 2019 Lakshmi Sundar

Whether the focus is endpoint adjudication, aggregate data monitoring or safety assessment, the clinical and device development industry clearly understands the value of establishing expert scientific committees to provide oversight on study data. These expert committee assessments provide validation on clinical data as additional support for regulatory submissions and commercial strategy. What is less well understood, however, is the importance of independent expertise. Without independent expertise, sponsors risk biased decision-making, conflicts of interest, potential clinical delays and squandered resources that could otherwise be avoided.

About the Author

Lakshmi Sundar

Lakshmi Sundar is the Head of Business Transformation at WCG ACI Clinical.

Follow on Linkedin More Content by Lakshmi Sundar
Previous Flipbook
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
Written Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?

Next Flipbook
Invert to Convert: Rethinking Patient Recruitment and Enrollment Strategies
Invert to Convert: Rethinking Patient Recruitment and Enrollment Strategies